Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

Late-Stage Pipeline Advancements and Novel Therapies Position Sector for Accelerated Growth and Major Value Catalysts   New York, NY –February 24, 2026 – Market News Updates News Commentary – Mental health disorders—including depression, anxiety, PTSD, and bipolar disorder—continue to represent one of the largest and fastest-growing areas of unmet medical need worldwide. According to the […]

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio   This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form base shelf prospectus dated September 17, 2025, as […]

Accelerated Engineering Software and Certified Composite Production Capturing Share of $100B+ Aerospace Market

Built for Scale: High-Performance Engineering Software and Aerospace Composite Production Converge in Multi-Billion-Dollar Defense Opportunity   New York, NY – February 24, 2026 – Market News Updates News Commentary – Advanced computational acceleration software is transforming how drones and defense systems are designed and tested. Instead of waiting weeks or months for simulation results, engineers […]

VisionWave Announces Execution of Definitive Agreement to Acquire a 51% Controlling Stake in Certified Aerospace Manufacturer Supporting Structural Components in Systems Publicly Known as Iron Dome and Barak 8 — Combining QSpeed™ Platform and Previously Announced $10 Million Development SOW to Build Scalable Defense Industrial Platform

51% Majority Control of Profitable Aerospace-Certified Composite Platform; Option to Acquire Remaining 49% — $50 Million Independent Valuation   West Hollywood, CA – February 24, 2026 — VisionWave Holdings Inc. (NASDAQ: VWAV) (“VisionWave” or the “Company”) today announced it has executed a binding definitive agreement to acquire a 51% controlling interest in C.M. Composite Materials […]